Skip to main content

Kazimi A J's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Oct 1, 2021

Accession no.
0001209191-21-058517
Filed
Oct 1, 2021
Trade date
Sep 1-30, 2021
Filing delay
30 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $891.15. It was filed 30 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kazimi A JCIK 0001075050Director, Officer (Chairman and CEO), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 1, 2021Common StockPPurchaseAcquired+15$2.88+$43.25,766,159Direct
Sep 2, 2021Common StockPPurchaseAcquired+15$2.88+$43.25,769,174Direct
Sep 3, 2021Common StockPPurchaseAcquired+15$2.85+$42.755,769,189Direct
Sep 7, 2021Common StockPPurchaseAcquired+15$2.79+$41.855,769,204Direct
Sep 8, 2021Common StockPPurchaseAcquired+15$2.89+$43.355,769,219Direct
Sep 9, 2021Common StockPPurchaseAcquired+15$2.77+$41.555,769,234Direct
Sep 10, 2021Common StockPPurchaseAcquired+15$2.78+$41.75,769,249Direct
Sep 13, 2021Common StockPPurchaseAcquired+15$2.96+$44.45,769,264Direct
Sep 14, 2021Common StockPPurchaseAcquired+15$3.02+$45.35,769,279Direct
Sep 15, 2021Common StockPPurchaseAcquired+15$2.86+$42.95,769,294Direct
Sep 16, 2021Common StockPPurchaseAcquired+15$2.91+$43.655,769,309Direct
Sep 17, 2021Common StockPPurchaseAcquired+15$2.85+$42.755,769,324Direct
Sep 20, 2021Common StockPPurchaseAcquired+15$2.82+$42.35,769,339Direct
Sep 21, 2021Common StockPPurchaseAcquired+15$2.81+$42.155,769,354Direct
Sep 22, 2021Common StockPPurchaseAcquired+15$2.76+$41.45,769,369Direct
Sep 23, 2021Common StockPPurchaseAcquired+15$2.75+$41.255,769,384Direct
Sep 24, 2021Common StockPPurchaseAcquired+15$2.74+$41.15,769,399Direct
Sep 27, 2021Common StockPPurchaseAcquired+15$2.79+$41.855,769,414Direct
Sep 28, 2021Common StockPPurchaseAcquired+15$2.76+$41.45,769,429Direct
Sep 29, 2021Common StockPPurchaseAcquired+15$2.82+$42.35,769,444Direct
Sep 30, 2021Common StockPPurchaseAcquired+15$2.72+$40.85,769,459Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)